CCC: Continuous Chest Compressions vs AHA Standard CPR of 30:2

Sponsor
University of Washington (Other)
Overall Status
Completed
CT.gov ID
NCT01372748
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (NIH), Canadian Institutes of Health Research (CIHR) (Other), Heart and Stroke Foundation of Canada (Other), American Heart Association (Other), Defence Research and Development Canada (Industry), U.S. Army Medical Research and Development Command (U.S. Fed)
23,711
7
2
53
3387.3
63.9

Study Details

Study Description

Brief Summary

The primary aim of the trial is to compare survival to hospital discharge after continuous chest compressions (CCC) versus standard American Heart Association (AHA) recommended cardiopulmonary resuscitation (CPR) with interrupted chest compressions (ICC) in patients with out-of-hospital cardiac arrest (OOHCA). The primary null hypothesis will be that the rate of survival to hospital discharge is not affected by use of continuous compressions with passive or positive pressure ventilation (intervention group) versus CPR with compressions interrupted for ventilation at a ratio of 30:2 (control group).

Condition or Disease Intervention/Treatment Phase
  • Other: Standard CPR
  • Other: Continuous chest compressions
Phase 4

Detailed Description

The primary aim of the trial is to compare survival to hospital discharge after continuous chest compressions (CCC) versus standard American Heart Association (AHA) recommended cardiopulmonary resuscitation (CPR) with interrupted chest compressions (ICC) in patients with out-of-hospital cardiac arrest (OOHCA). For this study, CCC consists of a series of three cycles of continuous chest compressions without pauses for ventilation followed by rhythm analysis or until restoration of spontaneous circulation (ROSC), whichever occurs first. ICC consists of series of three cycles of standard CPR each cycle comprised of chest compressions with interposed ventilations at a compression:ventilation ratio of 30:2 (per AHA guidelines) followed by rhythm analysis or until ROSC, whichever occurs first. In either patient group, the duration of manual CPR before the first rhythm analysis will be 30 seconds or 120 seconds. This treatment period will be followed by two cycles of compressions then rhythm analysis (i.e. each of approximately 2 minutes duration) in either group. Other aims of the trial are to compare survival to discharge among patients grouped by first-recorded rhythm or other a priori subgroups, as well as to compare neurological status at discharge, mechanistic outcomes or adverse events between control and intervention groups.

Study Design

Study Type:
Interventional
Actual Enrollment :
23711 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Trial Of Continuous Compressions Versus Standard CPR In Patients With Out-Of-Hospital Cardiac Arrest
Study Start Date :
Jun 1, 2011
Actual Primary Completion Date :
Aug 1, 2015
Actual Study Completion Date :
Nov 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Standard CPR

American Heart Association (AHA)recommended cardiopulmonary resuscitation (CPR) of 30 compressions with brief pause for 2 ventilations

Other: Standard CPR
30:2 CPR consists of 3 cycles of standard CPR with each cycle consisting of 30 chest compressions with a pause for 2 ventilations at a compression:ventilation ratio of 30:2. CCC consists of a series of three cycles of continuous chest compressions without pauses for ventilation. In either group, each cycle will be followed by rhythm analysis until three cycles are completed or restoration of spontaneous circulation (ROSC), whichever occurs first.

Experimental: Continuous chest compressions

Continuous compression CPR

Other: Continuous chest compressions
Continuous chest compressions during the first 6 minutes of the resuscitation.

Outcome Measures

Primary Outcome Measures

  1. Number of Participants Who Survive From the Time of Cardiac Arrest to Hospital Discharge [Patients will be followed from the time of the cardiac arrest until death or hospital discharge, whichever occurs first.]

    Patients may die in the field (outside of the hospital at the time of the cardiac arrest), at the emergency room, in the hospital, or they are discharged alive from the hospital.

Secondary Outcome Measures

  1. Percentage of Participants Scoring at or Below a 3 on the MRS Scale [Patients will be followed from the time of the cardiac arrest until death or hospital discharge, whichever occurs first.]

    Neurologic status at discharge will be assessed using the modified Rankin Score (MRS). A higher value indicates a worse outcome. 0-No symptoms at all; 1-No significant disability despite symptoms; able to carry out all usual duties and activities, 2-Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance, 3-Moderate disability; requiring some help, but able to walk without assistance; 4-Moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance, 5-Severe disability; bedridden, incontinent and requiring constant nursing care and attention; 6-Dead

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 18 years or more (or local age of consent);

  • Initial fire/Emergency Medical Services (EMS) chest compressions provided by Resuscitation Outcomes Consortium (ROC) study participating agency dispatched to the scene;

  • Lack of the exclusion criteria below

Exclusion Criteria:
  • EMS witnessed arrest;

  • Written do not attempt resuscitation (DNAR) orders;

  • Obvious primary asphyxia or respiratory cause of arrest (drowning, strangulation, hanging)

  • Advanced airway placed prior to ROC EMS arrival, or pre-existing tracheostomy

  • Traumatic cause (blunt, penetrating, burn) of arrest;

  • Known prisoners;

  • Known pregnancy;

  • Uncontrolled bleeding or exsanguination

  • Mechanical compression device used during study-assigned compression cycles

Contacts and Locations

Locations

Site City State Country Postal Code
1 Alabama Resuscitation Center Birmingham Alabama United States 35294
2 The Pittsburgh Resuscitation Network, University of Pittsburgh Pittsburgh Pennsylvania United States 15261
3 Dallas Center for Resuscitation Research, University of Texas Southwestern Medical Center Dallas Texas United States 75390
4 Seattle-King County Center for Resuscitation Research Seattle Washington United States 98195-6422
5 Milwaukee Resuscitation Network, Medical College of Wisconsin Milwaukee Wisconsin United States 53226
6 University of Ottawa/University of British Columbia Collaborative RCC, Ottawa Health Research Ottawa Ontario Canada K1Y 4E9
7 Rescu Toronto Ontario Canada M5B 1W8

Sponsors and Collaborators

  • University of Washington
  • National Heart, Lung, and Blood Institute (NHLBI)
  • Canadian Institutes of Health Research (CIHR)
  • Heart and Stroke Foundation of Canada
  • American Heart Association
  • Defence Research and Development Canada
  • U.S. Army Medical Research and Development Command

Investigators

  • Study Chair: Myron Weisfeldt, MD, MD, Johns Hopkins University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Susanne May, Principal Investigator, University of Washington
ClinicalTrials.gov Identifier:
NCT01372748
Other Study ID Numbers:
  • 40404-B
  • 5U01HL077863-07
First Posted:
Jun 14, 2011
Last Update Posted:
Dec 28, 2016
Last Verified:
Nov 1, 2016
Keywords provided by Susanne May, Principal Investigator, University of Washington
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail In this cluster randomized crossover trial, there are situations where age and gender are not known prior to the treatment being administered. These missing data account for the discrepancy between the enrollment number in the protocol section (23,711) and those in the participant flow module (23,687).
Arm/Group Title Standard CPR Continuous Chest Compressions
Arm/Group Description American Heart Association (AHA)recommended cardiopulmonary resuscitation (CPR) of 30 compressions with brief pause for 2 ventilations Standard CPR: 30:2 CPR consists of 3 cycles of standard CPR with each cycle consisting of 30 chest compressions with a pause for 2 ventilations at a compression:ventilation ratio of 30:2. CCC consists of a series of three cycles of continuous chest compressions without pauses for ventilation. In either group, each cycle will be followed by rhythm analysis until three cycles are completed or restoration of spontaneous circulation (ROSC), whichever occurs first. Continuous compression CPR Continuous chest compressions: Continuous chest compressions during the first 6 minutes of the resuscitation.
Period Title: Overall Study
STARTED 11045 12642
COMPLETED 11022 12603
NOT COMPLETED 23 39

Baseline Characteristics

Arm/Group Title Standard CPR Continuous Chest Compressions Total
Arm/Group Description American Heart Association (AHA)recommended cardiopulmonary resuscitation (CPR) of 30 compressions with brief pause for 2 ventilations Standard CPR: 30:2 CPR consists of 3 cycles of standard CPR with each cycle consisting of 30 chest compressions with a pause for 2 ventilations at a compression:ventilation ratio of 30:2. CCC consists of a series of three cycles of continuous chest compressions without pauses for ventilation. In either group, each cycle will be followed by rhythm analysis until three cycles are completed or restoration of spontaneous circulation (ROSC), whichever occurs first. Continuous compression CPR Continuous chest compressions: Continuous chest compressions during the first 6 minutes of the resuscitation. Total of all reporting groups
Overall Participants 11045 12642 23687
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
66.2
(17.0)
66.4
(17.2)
66.3
(17.1)
Gender (Count of Participants)
Female
3926
35.5%
4618
36.5%
8544
36.1%
Male
7119
64.5%
8024
63.5%
15143
63.9%
Race (NIH/OMB) (Count of Participants)
American Indian or Alaska Native
14
0.1%
12
0.1%
26
0.1%
Asian
123
1.1%
140
1.1%
263
1.1%
Native Hawaiian or Other Pacific Islander
23
0.2%
28
0.2%
51
0.2%
Black or African American
1246
11.3%
1350
10.7%
2596
11%
White
1795
16.3%
1931
15.3%
3726
15.7%
More than one race
3
0%
1
0%
4
0%
Unknown or Not Reported
7841
71%
9180
72.6%
17021
71.9%
Region of Enrollment (participants) [Number]
Canada
6711
60.8%
8010
63.4%
14721
62.1%
United States
4334
39.2%
4632
36.6%
8966
37.9%

Outcome Measures

1. Primary Outcome
Title Number of Participants Who Survive From the Time of Cardiac Arrest to Hospital Discharge
Description Patients may die in the field (outside of the hospital at the time of the cardiac arrest), at the emergency room, in the hospital, or they are discharged alive from the hospital.
Time Frame Patients will be followed from the time of the cardiac arrest until death or hospital discharge, whichever occurs first.

Outcome Measure Data

Analysis Population Description
The primary aim of the trial is to compare survival to hospital discharge after continuous chest compressions (CCC) versus standard American Heart Association (AHA) recommended cardiopulmonary resuscitation (CPR) with interrupted chest compressions (ICC) in patients with out-of-hospital cardiac arrest (OOHCA).
Arm/Group Title Standard CPR Continuous Chest Compressions
Arm/Group Description American Heart Association (AHA)recommended cardiopulmonary resuscitation (CPR) of 30 compressions with brief pause for 2 ventilations Standard CPR: 30:2 CPR consists of 3 cycles of standard CPR with each cycle consisting of 30 chest compressions with a pause for 2 ventilations at a compression:ventilation ratio of 30:2. CCC consists of a series of three cycles of continuous chest compressions without pauses for ventilation. In either group, each cycle will be followed by rhythm analysis until three cycles are completed or restoration of spontaneous circulation (ROSC), whichever occurs first. Continuous compression CPR Continuous chest compressions: Continuous chest compressions during the first 6 minutes of the resuscitation.
Measure Participants 11022 12603
Number [participants]
1072
9.7%
1127
8.9%
2. Secondary Outcome
Title Percentage of Participants Scoring at or Below a 3 on the MRS Scale
Description Neurologic status at discharge will be assessed using the modified Rankin Score (MRS). A higher value indicates a worse outcome. 0-No symptoms at all; 1-No significant disability despite symptoms; able to carry out all usual duties and activities, 2-Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance, 3-Moderate disability; requiring some help, but able to walk without assistance; 4-Moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance, 5-Severe disability; bedridden, incontinent and requiring constant nursing care and attention; 6-Dead
Time Frame Patients will be followed from the time of the cardiac arrest until death or hospital discharge, whichever occurs first.

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Standard CPR Continuous Chest Compressions
Arm/Group Description American Heart Association (AHA)recommended cardiopulmonary resuscitation (CPR) of 30 compressions with brief pause for 2 ventilations Standard CPR: 30:2 CPR consists of 3 cycles of standard CPR with each cycle consisting of 30 chest compressions with a pause for 2 ventilations at a compression:ventilation ratio of 30:2. CCC consists of a series of three cycles of continuous chest compressions without pauses for ventilation. In either group, each cycle will be followed by rhythm analysis until three cycles are completed or restoration of spontaneous circulation (ROSC), whichever occurs first. Continuous compression CPR Continuous chest compressions: Continuous chest compressions during the first 6 minutes of the resuscitation.
Measure Participants 10892 12550
Number [percentage of participants]
7.7
0.1%
7.0
0.1%

Adverse Events

Time Frame Adverse event data were collected from the time a participating agency arrived on scene and up to 24 hours after Emergency Department arrival
Adverse Event Reporting Description The following are commonly observed in patients who experience cardiac arrest or resuscitative efforts, and may or may not be attributable to specific resuscitation therapies. These were monitored and reported but not considered as adverse events of the study intervention. These include, but not limited to: pulmonary edema, airway bleeding, death, Clinical diagnoses of pneumonia, sepsis, cerebral bleeding, stroke, seizures, rearrest, serious rib fractures, and sternal fractures.
Arm/Group Title Standard CPR Continuous Chest Compressions
Arm/Group Description American Heart Association (AHA)recommended cardiopulmonary resuscitation (CPR) of 30 compressions with brief pause for 2 ventilations Standard CPR: 30:2 CPR consists of 3 cycles of standard CPR with each cycle consisting of 30 chest compressions with a pause for 2 ventilations at a compression:ventilation ratio of 30:2. CCC consists of a series of three cycles of continuous chest compressions without pauses for ventilation. In either group, each cycle will be followed by rhythm analysis until three cycles are completed or restoration of spontaneous circulation (ROSC), whichever occurs first. Continuous compression CPR Continuous chest compressions: Continuous chest compressions during the first 6 minutes of the resuscitation.
All Cause Mortality
Standard CPR Continuous Chest Compressions
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total / (NaN) / (NaN)
Serious Adverse Events
Standard CPR Continuous Chest Compressions
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/11045 (0%) 0/12642 (0%)
Other (Not Including Serious) Adverse Events
Standard CPR Continuous Chest Compressions
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 1197/11045 (10.8%) 1310/12642 (10.4%)
Gastrointestinal disorders
Emesis 1197/11045 (10.8%) 1310/12642 (10.4%)
Respiratory, thoracic and mediastinal disorders
Airway Bleed 764/11045 (6.9%) 881/12642 (7%)
Pulmonary Edema 1072/11045 (9.7%) 1137/12642 (9%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.

Results Point of Contact

Name/Title Dr. Susanne May
Organization University of Washington, Resuscitation Outcomes Consortium
Phone 206-685-1302
Email rochelp@uwctc.org
Responsible Party:
Susanne May, Principal Investigator, University of Washington
ClinicalTrials.gov Identifier:
NCT01372748
Other Study ID Numbers:
  • 40404-B
  • 5U01HL077863-07
First Posted:
Jun 14, 2011
Last Update Posted:
Dec 28, 2016
Last Verified:
Nov 1, 2016